BODYCOTE PLC (`the Company') Directorate Change - Change in Director's Particulars 5 March 2014 In accordance with paragraph 9.6.14 of the Listing Rules, the Company advises that it has today been notified that John Biles, Non-Executive Director, has been appointed as a Non-Executive Director of Skyepharma PLC with effect from 5 March 2014. Contact for queries:
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
695.5 GBX | +0.22% | +0.14% | +16.90% |
01/05 | EXECUTIVE CHANGES: New chairs for CVS Group, LSL Property and Videndum | AN |
03/04 | Jefferies Raises Bodycote PT, Maintains Buy Rating | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.90% | 1.63B | |
+11.24% | 82.83B | |
+17.86% | 69.72B | |
+20.14% | 37.53B | |
+14.52% | 31.66B | |
+12.78% | 27.96B | |
+2.46% | 26.56B | |
+13.70% | 25.65B | |
+0.96% | 25.46B | |
+15.63% | 24.44B |
- Stock Market
- Equities
- BOY Stock
- News Bodycote plc
- Bodycote PLC : - Change in Director's Particulars